• Home
  • Articles
  • COVID-19
  • News
    • Biotech News – Featured
    • Biotech News
    • BioGadgets
  • Interviews
    • Interviews – Academia
    • Interviews – Industry
  • Issues
  • Subscribe
  • Board
  • Advertise
Facebook Twitter Instagram
Trending
  • Highlights of India’s first Biotech startup Expo
  • NTU Singapore scientists develop a ‘fabric’ that turns body movement into electricity
  • Researchers who jumped into the field from distant disciplines published lower impact work, study finds
  • Amrita Vishwa Vidyapeetham gets CDSCO nod for clinical trials of first-of-its-kind synthetic jaw-bone graft
  • AstraZeneca Covid-19 vaccines which uses a chimpanzee adenovirus inked to monkeypox outbreak
  • Concerns Mount Over COVID-19 ‘Rebounds’ After Treatment With Pfizer’s Paxlovid
  • Moderna and Pfizer: Lawsuits and Charitable Giving
  • European Commission Approves Two GM Crops for Food and Feed
Biotech Express Magazine
  • Home
  • Articles
  • COVID-19
  • News
    • Biotech News – Featured
    • Biotech News
    • BioGadgets
  • Interviews
    1. Interviews – Academia
    2. Interviews – Industry
    Featured
    January 16, 20211

    Interview – Prof Rajeev K Varshney “The Youngest Indian Scientist (47)” who achieved an h-index of 100 recently

    Recent
    March 30, 2022

    Interview- Bioenergy: India’s Ministry of New and Renewable Energy started almost four decades ago…but did not catch up…, Professor Ashok Pandey

    January 24, 2022

    Interview: Prof Kailash Chander Bansal, Secretary, National Academy of Agricultural Sciences (NAAS), India

    January 23, 2022

    Interview – Dr Heera Lal: How an IAS officer using Biotech approaches to transform Indian villages into “Organic Villages”

  • Issues
  • Subscribe
  • Board
  • Advertise
Biotech Express Magazine
You are at:Home»Articles»Obituary – Hyderabad-based biotechnologist Dr B S Bajaj passes away at 93

Obituary – Hyderabad-based biotechnologist Dr B S Bajaj passes away at 93

0
By Biotech Express on August 16, 2020 Articles

Dr. B.S. Bajaj (DoB: 19/9/1927), founder of Federation of Asian Biotech Associations (FABA), which organizes BioAsia, a  prestigious global Bio Business Forum held every year in Hyderabad in association with the Government of Telangana, passed away on 28th July, 2020.

Dr. B. S. Bajaj, MSc; PhD; FPSI was the Founder and Chairman – All India Biotech Association-Southern Chapter (AIBA-SC), Founder and Secretary General – Federation of Asian Biotech Associations (FABA), and former member, AP Govt. Biotech Advisory Council, former member of Board of Directors of NATCO Pharma Ltd, Pacific Hospital (Pvt) Ltd, Otira Pharmaceuticals Private Ltd., and Transcell Biologics (Pvt) Ltd, Confederation of Indian Industry (CII) and National Committee on Biotechnology.

Dr. B.S. Bajaj had served as General Manager, IDPL, Rishikesh (1981-1985), Executive Director, Torrent Gujarat Biotech Ltd, Vadodara(1991-1998), Director, NATCO Pharma, Hyderabad (2002-2008). He was a member of SBTIC incubation center set up by the Department of Biotechnology, Government of India in Genome valley and also served as a member of Scientific Advisory Committees of CSIR Laboratories. He was the Vice-Chairman of Export Promotion Forum in Biotechnology, Govt. of India. He had over 50 years of experience in R&D in the areas of pharmaceuticals and antibiotics in India.

Dr. Bajaj has made immense contribution in the growth of Pharma and Biotechnology industries in India. In 1980’s while working in Indian Drugs and Pharmaceutical Limited (IDPL) Rishikesh, Vidharbhaa, he played a key role in getting technology transfer for antibiotic research and manufacturing from different countries to Indian Pharma companies. With this technology transfer agreement, Indian Pharma companies could manufacture drugs at a much cheaper cost.

He was instrumental in expansion and modernization of IDPL, Rishikesh plant and setting up of grass-root highly automatic Penicillin G fermentation plant at Baroda, from design to commissioning and stabilization. He thus made significant contribution to make the Country self-sufficient from 80% import of domestic requirements to surplus availability from indigenous sources, together with some other Units. In the academic front, he had a strong R&D experience, had published more than 75 scientific publications and guided several students for post-graduate and PhD Degrees.

He had spent more than a decade in creating global bio-business and Pharma platforms and forums to drive investments into these sectors in India. Under the fold of FABA and BioAsia Dr. Bajaj boosted bio-economy in India, particularly to the state of erstwhile Andhra Pradesh and the present Telangana.

Through his superior leadership and exceptional professionalism, he had been able to efficiently conduct several bio-partnering meetings involving prestigious multinational companies (MNCs) leading to millions of dollars of investments in India. He played a key role in bringing biotech policy for the state of earlier Andhra Pradesh and recommended the same to Government of India.

Several memoranda of understanding (MOUs) had been signed with the international organizations like BioCat of Spain, Catalonia Government, European Federation of Biotechnology, Russian Biotechnology Society, Association of German Biotech Companies (VBU), Bio-industry Park Canavese, Italy to bring together industry in all these countries with India. His most distinguished achievement has been bringing 20 Asian countries under the fold of Federation of Asian Biotech Associations and help in bilateral agreements for export of medicines.

Dr.Bajaj had worked with the local Government in bringing biotech cluster under one roof called “Genome Valley”. Today Genome Valley is the most successful bio-cluster in the country with 300+ Pharma and Biotech companies- major, small and medium range including start-up companies. The Genome Valley has prestigious companies like Bharath Biotech and Biological E- Limited producing vaccines; Novartis, Vimta Lab and others. I consider this was the most notable achievement of Dr. Bajaj.

Dr. Bajaj ensured industry-academia interface and helped formulate the first biotech policy of Telangana that paved the way for the growth of Genome Valley and BioAsia as an annual event to showcase it. He has spent more than a decade in creating global bio-business and Pharma platforms and form to drive investments into these sectors in India. Through superior leadership and exceptional commitment and professionalism, he had been able to efficiently conduct several bio-partnering meetings involving prestigious MNCs leading to millions of dollars of investments into India. Dr. Bajaj has given to India and the world, BioAsia, to boost bio-economy globally.

BioAsia also provided the platform to recognise the services rendered by distinguished scientists to the field of Biotechnology through “Genome Valley Excellence Awards”, and FABA Special Award”, for young scientists in the form of “BioAsia Innovation Awards” and students with “Young Minds Awards”. Some of these awardees include Nobel Laureates and other distinguished scientists around the world. Some of these include Dr. MK Bhan, Prof. E. Premkumar Reddy, Prof. G. Padmanabhan, Prof. Guntaka V Rama Reddy etc.

Dr. Bajaj had bestowed with several awards which include, BioAsia 2008 Award, Maryland India Business Roundtable (MIBRT), Inc., U.S.A bestowed him with an award for “Global leadership, commitment, vision and efforts to promote Biotechnology and Life Sciences for the last 50 years and for organizing BioAsia conferences” and Government of Catalonia (Spain) felicitation for fostering partnership between Andhra Pradesh and Catalonia, State of Spain, in Biotechnology on February 3, 2010, during BioAsia by presenting a Gold Plate with citation and a letter of appreciation from the Vice President of Catalonia Government. During BioAsia 2019, the Global Bio Business Forum, Dr. Bajaj was awarded with the FABA Lifetime Achievement Award for his significant contribution in the growth of biotechnology in India.

Another dream project of Dr. Bajaj was FABA Academy, which he witnessed its launching on 19th Feb, 2020 during BioAsia 2020. FABA Academy forms a bridge between the Academy and Industry in human resources development. The focus is on skill development among the science graduates and post graduates so as to make them industry-ready. The EC members of FABA and the Advisory committee of FABA Academy are highly indebted to Dr. Bajaj for conceptualizing a forum that enables the academy and industry together and for providing a global platform to promote Parma and Biotech industry in the form of BioAsia.

Prof. P Reddanna
Executive President,
Federation of Asian Biotech Association (FABA)
FABA website: http://biofaba.org/

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Biotech Express
  • Website
  • Facebook
  • Twitter
  • LinkedIn

ISSN: 2454-6968 | Biotech Express Magazine publishes articles in the field of biotechnology and allied sciences in a way that have never been presented earlier. It publishes Editorials, Guest Articles, Reports, Interviews, Current News of Govt. Academics and Business, Research Highlights and Notifications of Events, Jobs, Research Proposals in the field of Biotechnology, Biological Sciences, Life Sciences, Microbiology, Biochemistry, Neurosciences, Genetics, Medical Sciences, BioPharma etc.

Related Posts

No Vaccine Mandates after supreme court order, next compensation to AEFI survivors from COVID Vaccine makers possible?

Letter: Public Health Bill to be presented in the Monsoon session 2022 is Illegal, Unconstitutional and Arbitrary: Dr Maya Valecha

Paid publishing in science has killed peer review system, says CSIR’s ex-chief Shekhar Mande

Leave A Reply Cancel Reply

Current Issue – May 2022

                   VIEW SUBSCRIPTION PLANS

JOBS/NOTIFICATIONS

   

         CLICK HERE FOR RECENT NOTICES

Recent Posts
  • Highlights of India’s first Biotech startup Expo June 13, 2022
  • NTU Singapore scientists develop a ‘fabric’ that turns body movement into electricity June 6, 2022
  • Researchers who jumped into the field from distant disciplines published lower impact work, study finds May 30, 2022
  • Amrita Vishwa Vidyapeetham gets CDSCO nod for clinical trials of first-of-its-kind synthetic jaw-bone graft May 26, 2022
  • AstraZeneca Covid-19 vaccines which uses a chimpanzee adenovirus inked to monkeypox outbreak May 25, 2022
  • Concerns Mount Over COVID-19 ‘Rebounds’ After Treatment With Pfizer’s Paxlovid May 25, 2022
  • Moderna and Pfizer: Lawsuits and Charitable Giving May 25, 2022
  • European Commission Approves Two GM Crops for Food and Feed May 25, 2022
  • Ayush Ministry, DBT sign MoU for cooperation on evidence-based biotech interventions in Ayush sector May 24, 2022
  • CCI, India merger approved absorption of Covidshield Technologies into Biocon Biologics May 20, 2022
  • No Vaccine Mandates after supreme court order, next compensation to AEFI survivors from COVID Vaccine makers possible? May 19, 2022
  • Industry lobbying on WHO overshadowing public health policy, researchers suggest May 18, 2022
  • Letter: Public Health Bill to be presented in the Monsoon session 2022 is Illegal, Unconstitutional and Arbitrary: Dr Maya Valecha May 15, 2022
  • Paid publishing in science has killed peer review system, says CSIR’s ex-chief Shekhar Mande May 15, 2022
  • Bill Gates tests positive for COVID-19 even after many booster doses, mocked on twitter May 10, 2022
  • Another Ivermectin COVID-19 paper retracted May 8, 2022
  • COVID-19 spike protein paper retracted May 7, 2022
  • Killer Music? Can sound make a clot in a boy who died while dancing or it is related to COVID vaccination May 7, 2022
  • Clotting Risks Cause FDA to Restrict Use of J&J COVID Vaccine May 6, 2022
  • Department of Pharmaceuticals releases “Common Guidelines on Pharmaceutical Innovation and Entrepreneurship” for academic institutions May 6, 2022
  • No medical care for 45% of recorded deaths in 2020, highest ever in India: New data May 6, 2022
  • Indian opposition seeks higher compensation for COVID deaths after damning WHO report May 6, 2022
  • Redcliffe Lifetech raises $61 million in Series B funding May 6, 2022
  • Engineers Create an Enzyme That Breaks Down Plastic Waste in Hours, Not Decades May 5, 2022
  • Eris Lifesciences acquires 100% stake in Oaknet Healthcare for Rs 650 cr May 5, 2022
  • The Union Government has Lied to the Supreme Court in COVID Vaccines Case? May 5, 2022
  • COVID-19- vitamin D paper from India retracted by Springer Nature journal May 4, 2022
  • IISc develops 3D printed gloves for rehabilitating stroke patients May 4, 2022
  • A new wearable technology — for plants May 4, 2022
  • Sanofi India names Rodolfo Hrosz managing director effective June 1 May 4, 2022
Archives
Categories
  • Articles
  • Articles- Editorials
  • Articles- Guestorials
  • BioControversial
  • BioEvents
  • BioGadgets
  • BioPolicies
  • BioResearch – Academic
  • Biotech News
  • Biotech News – Featured
  • Contents
  • Interviews
  • Interviews – Academia
  • Interviews – Industry
  • SARS- CoV2 & COVID-19 Updates
  • startups
About Us

Biotech Express Magazine publishes articles in the field of biotechnology and allied sciences in a way that have never been presented earlier. It publishes Editorials, Guest Articles, Reports,  Interviews, Current News of Govt. Academics and Business, Research Highlights and Notifications of Events, Jobs, Research Proposals in the field of Biotechnology and allied sciences like Biological Sciences, Life Sciences, Microbiology, Biochemistry, Neurology, Genetics, Medical Sciences, BioPharma etc.

Call us: _91-9311986177

Email – biotechexpressindia@gmail.com

About Us

About Biotech Express

Advisory and Editorial Board

Contact Us

Policy and Guidelines

Submission policies

Peer review policy    

Copyright policy

 

Follow Us
  • Facebook
  • Twitter
We use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies. Copyright © 2013-2020 Biotech Express except certain content provided by third parties.

Type above and press Enter to search. Press Esc to cancel.